Logos Global Management LP Alnylam Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

  • $775 Million
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$127.18 - $173.91 $4.45 Million - $6.09 Million
-35,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $5.58 Million - $7.33 Million
35,000 New
35,000 $5.94 Million
Q2 2020

Aug 14, 2020
SELL
$104.21 - $156.44 $4.13 Million - $6.2 Million
-39,644 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$93.12 - $133.99 $3.69 Million - $5.31 Million
39,644 New
39,644 $4.32 Million

Others Institutions Holding ALNY

# of Institutions
806
Shares Held
116M
Call Options Held
584K
Put Options Held
648K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $55.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email